208 related articles for article (PubMed ID: 24432364)
1. Effect of sclerostin-neutralising antibody on periarticular and systemic bone in a murine model of rheumatoid arthritis: a microCT study.
Marenzana M; Vugler A; Moore A; Robinson M
Arthritis Res Ther; 2013; 15(5):R125. PubMed ID: 24432364
[TBL] [Abstract][Full Text] [Related]
2. Sclerostin inhibition reverses systemic, periarticular and local bone loss in arthritis.
Chen XX; Baum W; Dwyer D; Stock M; Schwabe K; Ke HZ; Stolina M; Schett G; Bozec A
Ann Rheum Dis; 2013 Oct; 72(10):1732-6. PubMed ID: 23666928
[TBL] [Abstract][Full Text] [Related]
3. IL-1 alpha beta blockade prevents cartilage and bone destruction in murine type II collagen-induced arthritis, whereas TNF-alpha blockade only ameliorates joint inflammation.
Joosten LA; Helsen MM; Saxne T; van De Loo FA; Heinegard D; van Den Berg WB
J Immunol; 1999 Nov; 163(9):5049-55. PubMed ID: 10528210
[TBL] [Abstract][Full Text] [Related]
4. Sclerostin-Antibody Treatment Decreases Fracture Rates in Axial Skeleton and Improves the Skeletal Phenotype in Growing oim/oim Mice.
Cardinal M; Dessain A; Roels T; Lafont S; Ominsky MS; Devogelaer JP; Chappard D; Mabilleau G; Ammann P; Nyssen-Behets C; Manicourt DH
Calcif Tissue Int; 2020 May; 106(5):494-508. PubMed ID: 32025752
[TBL] [Abstract][Full Text] [Related]
5. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB
Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663
[TBL] [Abstract][Full Text] [Related]
6. Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion.
Lubberts E; Koenders MI; Oppers-Walgreen B; van den Bersselaar L; Coenen-de Roo CJ; Joosten LA; van den Berg WB
Arthritis Rheum; 2004 Feb; 50(2):650-9. PubMed ID: 14872510
[TBL] [Abstract][Full Text] [Related]
7. TNF-alpha antibodies and osteoprotegerin decrease systemic bone loss associated with inflammation through distinct mechanisms in collagen-induced arthritis.
Saidenberg-Kermanac'h N; Corrado A; Lemeiter D; deVernejoul MC; Boissier MC; Cohen-Solal ME
Bone; 2004 Nov; 35(5):1200-7. PubMed ID: 15542046
[TBL] [Abstract][Full Text] [Related]
8. RANKL inhibition by osteoprotegerin prevents bone loss without affecting local or systemic inflammation parameters in two rat arthritis models: comparison with anti-TNFalpha or anti-IL-1 therapies.
Stolina M; Schett G; Dwyer D; Vonderfecht S; Middleton S; Duryea D; Pacheco E; Van G; Bolon B; Feige U; Zack D; Kostenuik P
Arthritis Res Ther; 2009; 11(6):R187. PubMed ID: 20003323
[TBL] [Abstract][Full Text] [Related]
9. Systemic Resolvin E1 (RvE1) Treatment Does Not Ameliorate the Severity of Collagen-Induced Arthritis (CIA) in Mice: A Randomized, Prospective, and Controlled Proof of Concept Study.
de Molon RS; Thurlings RM; Walgreen B; Helsen MM; van der Kraan PM; Cirelli JA; Koenders MI
Mediators Inflamm; 2019; 2019():5689465. PubMed ID: 31780864
[TBL] [Abstract][Full Text] [Related]
10. Induction of bone loss in DBA/1J mice immunized with citrullinated autologous mouse type II collagen in the absence of adjuvant.
Dusad A; Duryee MJ; Shaw AT; Klassen LW; Anderson DR; Wang D; Ren K; Gravallese EM; O'Dell JR; Mikuls TR; Thiele GM
Immunol Res; 2014 Jan; 58(1):51-60. PubMed ID: 24371010
[TBL] [Abstract][Full Text] [Related]
11. A short treatment with an antibody to sclerostin can inhibit bone loss in an ongoing model of colitis.
Eddleston A; Marenzana M; Moore AR; Stephens P; Muzylak M; Marshall D; Robinson MK
J Bone Miner Res; 2009 Oct; 24(10):1662-71. PubMed ID: 19419292
[TBL] [Abstract][Full Text] [Related]
12. TNF receptor gene therapy results in suppression of IgG2a anticollagen antibody in collagen induced arthritis.
Mukherjee P; Wu B; Mayton L; Kim SH; Robbins PD; Wooley PH
Ann Rheum Dis; 2003 Aug; 62(8):707-14. PubMed ID: 12860724
[TBL] [Abstract][Full Text] [Related]
13. Sclerostin Antibody Reverses Bone Loss by Increasing Bone Formation and Decreasing Bone Resorption in a Rat Model of Male Osteoporosis.
Li X; Ominsky MS; Villasenor KS; Niu QT; Asuncion FJ; Xia X; Grisanti M; Wronski TJ; Simonet WS; Ke HZ
Endocrinology; 2018 Jan; 159(1):260-271. PubMed ID: 29069393
[TBL] [Abstract][Full Text] [Related]
14. The inhibitory effects of a RANKL-binding peptide on articular and periarticular bone loss in a murine model of collagen-induced arthritis: a bone histomorphometric study.
Kato G; Shimizu Y; Arai Y; Suzuki N; Sugamori Y; Maeda M; Takahashi M; Tamura Y; Wakabayashi N; Murali R; Ono T; Ohya K; Mise-Omata S; Aoki K
Arthritis Res Ther; 2015 Sep; 17(1):251. PubMed ID: 26373710
[TBL] [Abstract][Full Text] [Related]
15. Vascular cell adhesion molecule-1 (VCAM-1) blockade in collagen-induced arthritis reduces joint involvement and alters B cell trafficking.
Carter RA; Campbell IK; O'Donnel KL; Wicks IP
Clin Exp Immunol; 2002 Apr; 128(1):44-51. PubMed ID: 11982589
[TBL] [Abstract][Full Text] [Related]
16. Sclerostin antibody inhibits skeletal deterioration due to reduced mechanical loading.
Spatz JM; Ellman R; Cloutier AM; Louis L; van Vliet M; Suva LJ; Dwyer D; Stolina M; Ke HZ; Bouxsein ML
J Bone Miner Res; 2013 Apr; 28(4):865-74. PubMed ID: 23109229
[TBL] [Abstract][Full Text] [Related]
17. Torilin ameliorates type II collagen-induced arthritis in mouse model of rheumatoid arthritis.
Endale M; Lee WM; Kwak YS; Kim NM; Kim BK; Kim SH; Cho J; Kim S; Park SC; Yun BS; Ko D; Rhee M
Int Immunopharmacol; 2013 Jun; 16(2):232-42. PubMed ID: 23623942
[TBL] [Abstract][Full Text] [Related]
18. Anti-arthritic and anti-inflammatory effects of (-)-Epicatechin-3-O-β-d-allopyranoside, a constituent of Davallia formosana.
Hsiao HB; Wu JB; Lin WC
Phytomedicine; 2019 Jan; 52():12-22. PubMed ID: 30599891
[TBL] [Abstract][Full Text] [Related]
19. Sclerostin antibody treatment enhances bone strength but does not prevent growth retardation in young mice treated with dexamethasone.
Marenzana M; Greenslade K; Eddleston A; Okoye R; Marshall D; Moore A; Robinson MK
Arthritis Rheum; 2011 Aug; 63(8):2385-95. PubMed ID: 21484764
[TBL] [Abstract][Full Text] [Related]
20. CARD11 blockade suppresses murine collagen-induced arthritis via inhibiting CARD11/Bcl10 assembly and T helper type 17 response.
Wang H; Zhao J; Zhang H; Huang Y; Wang S; Tu Q; Yang N
Clin Exp Immunol; 2014 May; 176(2):238-45. PubMed ID: 24443940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
